YPEG-rhEPO

YPEG-rhEPO · Xiamen Amoytop Biotech Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for YPEG-rhEPO, covering 2022-12-16 to 2022-12-16. Get the full timeline:

Most recent: Clinical Trial Update: A Study of YPEG-rhEPO in Patients Suffered From Anemia Due to Chronic Kidney Disease [Phase 2]